Short-term tocolytics for preterm delivery – current perspectives

References

• MartinJAHamiltonBEVenturaSJOstermanMMathewsTJBirths: final data for 2011National Vital Statistics Reports62Hyattsville, MD, USANational Center for Health Statistics2013
   Google Scholar
• American College of Obstetricians and Gynecologists; Committee on Practice Bulletins-ObstetricsACOG practice bulletin no 127: management of preterm laborObstet Gynecol201211961308131722617615
   PubMedGoogle Scholar
• MacDormanMFCallaghanWMMathewsTJHoyertDLKochanekKDTrends in preterm-related infant mortality by race and ethnicity, United States, 1999–2004Int J Health Serv200737463564118072312
   PubMed Web of Science ®Google Scholar
• MathewsTJMacDormanMFInfant mortality statistics from the 2007 period linked birth/infant death data setNatl Vital Stat Rep2011596130
   Google Scholar
• PetrouSThe economic consequences of preterm birth during the first 10 years of lifeBJOG2005112Suppl 1101515715587
   PubMed Web of Science ®Google Scholar
• Institute of MedicinePreterm Birth: Causes, Consequences, and PreventionWashington, DC, USANational Academies Press2006
   Google Scholar
• CrowleyPProphylactic corticosteroids for preterm birthCochrane Database Syst Rev20002CD00006510796110
   PubMedGoogle Scholar
• HaasDMCaldwellDMKirkpatrickPMcIntoshJJWeltonNJTocolytic therapy for preterm delivery: systematic review and network meta-analysisBMJ2012345e622623048010
   PubMed Web of Science ®Google Scholar
• HaasDMImperialeTFKirkpatrickPRKleinRWZollingerTWGolichowskiAMTocolytic therapy: a meta-analysis and decision analysisObstet Gynecol2009113358559419300321
   PubMed Web of Science ®Google Scholar
• CreasyRKResnikRIamsJDCreasy and Resnik’s Maternal Fetal Medicine: Principles and Practice6th edPhiladelphia, PA, USASaunders2009
   Google Scholar
• USFoodDrug AdministrationTerbutaline: Label change – warnings against use for treatment of preterm labor2001 Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm243843.htmAccessed December 17, 2013
   Google Scholar
• BergGAnderssonRGRydenGBeta-adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after beta-mimetic treatmentAm J Obstet Gynecol198515133923962982269
   PubMed Web of Science ®Google Scholar
• AnotayanonthSSubhedarNVGarnerPNeilsonJPHarigopalSBetamimetics for inhibiting preterm labourCochrane Database Syst Rev20044CD00435215495104
   PubMedGoogle Scholar
• PerryKGJrMorrisonJCRustOASullivanCAMartinRWNaefRW3rdIncidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusionAm J Obstet Gynecol19951734127312777485336
   PubMed Web of Science ®Google Scholar
• BenedettiTJMaternal complications of parenteral beta-sympathomimetic therapy for premature laborAm J Obstet Gynecol19831451166849333
   PubMed Web of Science ®Google Scholar
• OzcanTTuranCEkiciERitodrine tocolysis and neonatal intraventricular-periventricular hemorrhageGynecol Obstet Invest199539160627890256
   PubMed Web of Science ®Google Scholar
• PaltaMSadekMLimTSEvansMMcGuinnessGAssociation of tocolytic therapy with antenatal steroid administration and infant outcomes. Newborn Lung ProjectAm J Perinatol199815287929514131
   PubMed Web of Science ®Google Scholar
• Conde-AgudeloARomeroRKusanovicJPNifedipine in the management of preterm labor: a systematic review and metaanalysisAm J Obstet Gynecol20112042134e1e2021284967
   PubMed Web of Science ®Google Scholar
• NassarAHAounJUstaIMCalcium channel blockers for the management of preterm birth: a reviewAm J Perinatol2011281576620640972
   PubMed Web of Science ®Google Scholar
• KingJFFlenadyVJPapatsonisDNDekkerGACarbonneBCalcium channel blockers for inhibiting preterm labourCochrane Database Syst Rev20031CD00225512535434
   PubMedGoogle Scholar
• SteerCMPetrieRHA comparison of magnesium sulfate and alcohol for the prevention of premature laborAm J Obstet Gynecol1977129114331952
   PubMed Web of Science ®Google Scholar
• ElliottJPMagnesium sulfate as a tocolytic agentAm J Obstet Gynecol198314732772846624792
   PubMed Web of Science ®Google Scholar
• MaddenCOwenJHauthJCMagnesium tocolysis: serum levels versus successAm J Obstet Gynecol19901625117711802339717
   PubMed Web of Science ®Google Scholar
• GoldenbergRLThe management of preterm laborObstet Gynecol20021005 Pt 11020103712423870
   PubMed Web of Science ®Google Scholar
• MercerBMMerlinoAAMagnesium sulfate for preterm labor and preterm birthObstet Gynecol2009114365066819701047
   PubMed Web of Science ®Google Scholar
• Worldwide Atosiban versus Beta-agonists Study GroupEffectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study GroupBJOG2001108213314211236112
   PubMedGoogle Scholar
• RomeroRSibaiBMSanchez-RamosLAn oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescueAm J Obstet Gynecol200018251173118310819855
   PubMed Web of Science ®Google Scholar
• PapatsonisDFlenadyVColeSLileyHOxytocin receptor antagonists for inhibiting preterm labourCochrane Database Syst Rev20053CD00445216034931
   PubMedGoogle Scholar
• KingJFlenadyVColeSThorntonSCyclo-oxygenase (COX) inhibitors for treating preterm labourCochrane Database Syst Rev20052CD00199215846626
   PubMedGoogle Scholar
• DuckittKThorntonSNitric oxide donors for the treatment of preterm labourCochrane Database Syst Rev20023CD00286012137661
   PubMedGoogle Scholar
• Committee on Practice Bulletins-Obstetrics, The American College of Obstetricians and GynecologistsPractice bulletin no 130: prediction and prevention of preterm birthObstet Gynecol2012120496497322996126
   PubMedGoogle Scholar
• SuLLSamuelMChongYSProgestational agents for treating threatened or established preterm labourCochrane Database Syst Rev20101CD00677020091604
   PubMed Web of Science ®Google Scholar
• BreartGSureauCRumeau-RouquetteCA study of the comparative efficiency of ifenprodil and ritodrine in the treatment of threatened premature labourJ Gynecol Obstet Biol Reprod (Paris)197983261263 French39954
   PubMedGoogle Scholar
• CrowtherCAHillerJEDoyleLWHaslamRREffect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trialJAMA2003290202669267614645308
   PubMed Web of Science ®Google Scholar
• Abou-GhannamGUstaIMNassarAHIndomethacin in pregnancy: applications and safetyAm J Perinatol201229317518621786219
   PubMed Web of Science ®Google Scholar
• HaasDMQuinneySKClayJMNifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolyticAm J Perinatol201330427528122875663
   PubMed Web of Science ®Google Scholar
• AbduljalilKFurnessPJohnsonTNRostami-HodjeganASoltaniHAnatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modellingClin Pharmacokinet201251636539622515555
   PubMed Web of Science ®Google Scholar
• HaasDMQuinneySKMcCormickCLJonesDRRenbargerJLA pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolyticJ Matern Fetal Neonatal Med201225441942321644845
   PubMed Web of Science ®Google Scholar
• QuinneySKMohamedANHebertMFA semi-mechanistic metabolism model of CYP3A substrates in pregnancy: predicting changes in midazolam and nifedipine pharmacokineticsCPT Pharmacometrics Syst Pharmacol20121e223835882
   PubMedGoogle Scholar
• HaasDMD’AltonMPharmacogenetics and other reasons why drugs can fail in pregnancy: higher dose or different drug?Obstet Gynecol201212051176117923090536
   PubMed Web of Science ®Google Scholar
• LyellDJPullenKMMannanJMaintenance nifedipine tocolysis compared with placebo: a randomized controlled trialObstet Gynecol200811261221122619037029
   PubMed Web of Science ®Google Scholar